droxia
(HYDROXYUREA)H2-Pharma LLC
Usage: DROXIA is indicated for reducing the frequency of painful crises and minimizing the need for blood transfusions in patients with sickle cell anemia who experience recurrent moderate to severe painful crises.
3 results
hydrea
(HYDROXYUREA)H2-Pharma LLCUsage: HYDREA is indicated for the treatment of resistant chronic myeloid leukemia and for locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.siklos
(hydroxyurea)MedunikUsage: SIKLOS® is indicated for reducing the frequency of painful crises and the need for blood transfusions in adults and pediatric patients, 2 years and older, suffering from sickle cell anemia with recurrent moderate to severe painful crises.